Healthcare Sector Stocks
The Healthcare sector has a total of 1066 stocks, with a combined market cap of $8.26 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 39.79.
Market Cap
8.26T
Revenue
4.52T
Profits
207.58B
PE Ratio
39.79
Profit Margin
4.59%
Dividend Yield
0.44%
1066 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 829.55B | -0.91% | 1,465,074 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 580.40B | -0.85% | 4,437,756 | 94.19B |
| 3 | ABBV | AbbVie Inc. | 365.59B | -1.03% | 4,856,474 | 61.16B |
| 4 | AZN | AstraZeneca PLC | 314.50B | -0.32% | 1,281,645 | 58.74B |
| 5 | MRK | Merck & Co., Inc. | 298.79B | -0.02% | 4,837,460 | 65.01B |
| 6 | NVS | Novartis AG | 294.55B | -0.77% | 891,887 | 56.67B |
| 7 | UNH | UnitedHealth Group Incorporated | 255.38B | 1.48% | 5,373,842 | 447.57B |
| 8 | AMGN | Amgen Inc. | 184.67B | -1.54% | 2,133,076 | 36.75B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 181.35B | -0.67% | 1,178,503 | 44.56B |
| 10 | ABT | Abbott Laboratories | 178.17B | -0.55% | 6,984,302 | 44.33B |
| 11 | GILD | Gilead Sciences, Inc. | 173.93B | 0.30% | 2,265,964 | 29.44B |
| 12 | NVO | Novo Nordisk A/S | 163.33B | -0.84% | 11,418,886 | 48.59B |
| 13 | ISRG | Intuitive Surgical, Inc. | 160.74B | 0.11% | 888,700 | 10.06B |
| 14 | PFE | Pfizer Inc. | 158.31B | -1.73% | 25,054,392 | 62.58B |
| 15 | DHR | Danaher Corporation | 135.96B | 0.52% | 2,143,447 | 24.57B |
| 16 | SYK | Stryker Corporation | 127.17B | 0.23% | 998,233 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 121.14B | -0.45% | 7,822,765 | 48.19B |
| 18 | SNY | Sanofi | 115.12B | -0.61% | 1,386,198 | 54.85B |
| 19 | GSK | GSK plc | 113.45B | -0.56% | 2,046,273 | 43.97B |
| 20 | MDT | Medtronic plc | 110.77B | -0.40% | 3,441,419 | 35.48B |
| 21 | VRTX | Vertex Pharmaceuticals Incorporated | 110.47B | -1.01% | 671,894 | 12.00B |
| 22 | HCA | HCA Healthcare, Inc. | 108.19B | 2.56% | 598,503 | 75.60B |
| 23 | MCK | McKesson Corporation | 104.94B | -3.11% | 788,762 | 397.96B |
| 24 | CVS | CVS Health Corporation | 93.23B | -0.29% | 4,254,998 | 399.83B |
| 25 | BSX | Boston Scientific Corporation | 93.02B | -0.37% | 9,055,138 | 20.07B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 78.30B | 0.16% | 344,126 | 14.34B |
| 27 | CI | The Cigna Group | 72.69B | 2.10% | 1,027,687 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 66.47B | 0.62% | 1,588,557 | 199.13B |
| 29 | COR | Cencora, Inc. | 62.44B | -1.18% | 811,692 | 325.78B |
| 30 | MDLN | Medline Inc. | 57.64B | -0.90% | 5,419,472 | 28.43B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 56.91B | -2.77% | 3,584,064 | 28.48B |
| 32 | CAH | Cardinal Health, Inc. | 50.03B | -0.67% | 1,154,540 | 244.67B |
| 33 | ZTS | Zoetis Inc. | 49.92B | 0.27% | 1,295,139 | 9.47B |
| 34 | EW | Edwards Lifesciences Corporation | 46.81B | 0.17% | 2,214,980 | 6.07B |
| 35 | ARGX | argenx SE | 46.37B | 0.25% | 313,830 | 4.24B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 45.98B | 1.39% | 400,925 | 4.30B |
| 37 | BDX | Becton, Dickinson and Company | 44.23B | 0.52% | 1,597,902 | 21.92B |
| 38 | HLN | Haleon plc | 44.03B | -0.10% | 3,699,052 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.81B | 3.60% | 985,199 | 3.71B |
| 40 | ALC | Alcon Inc. | 36.84B | 0.09% | 577,542 | 10.40B |
| 41 | INSM | Insmed Incorporated | 35.36B | 0.85% | 1,515,575 | 606.42M |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 34.72B | -0.86% | 3,960,196 | 17.26B |
| 43 | ONC | BeOne Medicines AG | 33.53B | -2.69% | 183,762 | 5.34B |
| 44 | RMD | ResMed Inc. | 32.62B | 0.37% | 350,818 | 5.40B |
| 45 | A | Agilent Technologies, Inc. | 32.45B | -0.55% | 1,153,739 | 7.07B |
| 46 | GEHC | GE HealthCare Technologies Inc. | 32.12B | 0.07% | 1,628,728 | 20.63B |
| 47 | WAT | Waters Corporation | 29.83B | -0.05% | 487,474 | 3.17B |
| 48 | NTRA | Natera, Inc. | 29.04B | -1.50% | 808,762 | 2.31B |
| 49 | IQV | IQVIA Holdings Inc. | 28.66B | -1.47% | 849,657 | 16.31B |
| 50 | VEEV | Veeva Systems Inc. | 28.52B | 0.38% | 1,433,032 | 3.20B |
| 51 | RPRX | Royalty Pharma plc | 27.30B | -2.57% | 2,765,742 | 2.38B |
| 52 | PHG | Koninklijke Philips N.V. | 25.90B | 0.33% | 742,763 | 20.94B |
| 53 | MTD | Mettler-Toledo International Inc. | 25.65B | 0.53% | 67,989 | 4.03B |
| 54 | BIIB | Biogen Inc. | 25.29B | -2.82% | 1,759,781 | 9.89B |
| 55 | UTHR | United Therapeutics Corporation | 24.53B | -0.91% | 386,774 | 3.18B |
| 56 | DXCM | DexCom, Inc. | 24.33B | 1.59% | 1,913,005 | 4.66B |
| 57 | BNTX | BioNTech SE | 23.08B | 0.11% | 462,762 | 3.37B |
| 58 | LH | Labcorp Holdings Inc. | 22.62B | 0.27% | 298,474 | 13.95B |
| 59 | HUM | Humana Inc. | 21.93B | 2.71% | 1,647,565 | 129.66B |
| 60 | DGX | Quest Diagnostics Incorporated | 21.86B | 0.91% | 477,714 | 11.04B |
| 61 | STE | STERIS plc | 21.57B | 0.58% | 260,765 | 5.83B |
| 62 | ROIV | Roivant Sciences Ltd. | 19.95B | -1.59% | 3,668,253 | 13.31M |
| 63 | ILMN | Illumina, Inc. | 19.53B | 0.28% | 790,818 | 4.34B |
| 64 | MRNA | Moderna, Inc. | 19.34B | -0.87% | 3,479,926 | 1.94B |
| 65 | RVMD | Revolution Medicines, Inc. | 18.90B | -3.79% | 1,103,391 | - |
| 66 | INCY | Incyte Corporation | 18.88B | -1.12% | 760,813 | 5.14B |
| 67 | WST | West Pharmaceutical Services, Inc. | 18.50B | 0.80% | 503,961 | 3.07B |
| 68 | ZBH | Zimmer Biomet Holdings, Inc. | 17.61B | 0.12% | 975,974 | 8.23B |
| 69 | CNC | Centene Corporation | 17.41B | 0.83% | 3,277,440 | 176.15B |
| 70 | HOLX | Hologic, Inc. | 16.97B | 0.48% | 101,701,146 | 4.13B |
| 71 | GMAB | Genmab A/S | 16.77B | 0.91% | 1,184,410 | 3.72B |
| 72 | THC | Tenet Healthcare Corporation | 16.55B | 1.12% | 1,004,762 | 21.31B |
| 73 | VTRS | Viatris Inc. | 15.44B | -0.22% | 5,519,866 | 14.30B |
| 74 | RGC | Regencell Bioscience Holdings Limited | 15.28B | 0.32% | 116,382 | - |
| 75 | SMMT | Summit Therapeutics Inc. | 14.49B | -3.56% | 1,629,938 | - |
| 76 | PODD | Insulet Corporation | 14.33B | -0.40% | 944,761 | 2.71B |
| 77 | MEDP | Medpace Holdings, Inc. | 14.16B | -0.47% | 245,630 | 2.53B |
| 78 | BBIO | BridgeBio Pharma, Inc. | 14.01B | -1.19% | 468,361 | 502.08M |
| 79 | ASND | Ascendis Pharma A/S | 13.91B | -1.12% | 368,761 | 845.52M |
| 80 | COO | The Cooper Companies, Inc. | 13.71B | 0.17% | 1,986,516 | 4.15B |
| 81 | SNN | Smith & Nephew plc | 13.65B | 1.52% | 961,947 | 6.16B |
| 82 | NBIX | Neurocrine Biosciences, Inc. | 13.30B | 0.67% | 1,786,576 | 2.86B |
| 83 | PEN | Penumbra, Inc. | 12.97B | -0.15% | 285,006 | 1.40B |
| 84 | IONS | Ionis Pharmaceuticals, Inc. | 12.28B | -0.62% | 1,182,498 | 943.71M |
| 85 | ALGN | Align Technology, Inc. | 12.25B | 0.74% | 494,611 | 4.03B |
| 86 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.25B | -2.38% | 253,027 | 958.40M |
| 87 | FMS | Fresenius Medical Care AG | 12.07B | 0.31% | 247,871 | 23.05B |
| 88 | GMED | Globus Medical, Inc. | 11.98B | 0.77% | 693,875 | 2.94B |
| 89 | GH | Guardant Health, Inc. | 11.76B | -4.44% | 925,806 | 982.02M |
| 90 | ENSG | The Ensign Group, Inc. | 11.56B | 0.69% | 162,269 | 5.06B |
| 91 | JAZZ | Jazz Pharmaceuticals plc | 11.50B | -0.05% | 1,011,625 | 4.27B |
| 92 | EXEL | Exelixis, Inc. | 11.42B | 0.23% | 1,285,270 | 2.32B |
| 93 | ELAN | Elanco Animal Health Incorporated | 11.35B | -1.13% | 4,661,757 | 4.72B |
| 94 | UHS | Universal Health Services, Inc. | 11.08B | 2.62% | 648,522 | 17.36B |
| 95 | SOLV | Solventum Corporation | 10.97B | -0.50% | 683,075 | 8.33B |
| 96 | RDY | Dr. Reddy's Laboratories Limited | 10.94B | -1.35% | 1,257,303 | 3.85B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.81B | 1.28% | 1,269,722 | 3.22B |
| 98 | EHC | Encompass Health Corporation | 10.45B | 7.97% | 1,990,927 | 5.94B |
| 99 | DVA | DaVita Inc. | 10.02B | 3.12% | 362,860 | 13.64B |
| 100 | RVTY | Revvity, Inc. | 9.87B | -0.70% | 434,528 | 2.86B |
| 101 | MASI | Masimo Corporation | 9.32B | -0.06% | 866,435 | 1.53B |
| 102 | ABVX | ABIVAX Société Anonyme | 9.27B | 0.93% | 281,771 | 5.37M |
| 103 | BTSG | BrightSpring Health Services, Inc. | 8.88B | 0.95% | 1,268,689 | 12.91B |
| 104 | AXSM | Axsome Therapeutics, Inc. | 8.68B | 0.73% | 236,648 | 638.50M |
| 105 | PRAX | Praxis Precision Medicines, Inc. | 8.64B | -0.09% | 244,645 | 7.46M |
| 106 | PCVX | Vaxcyte, Inc. | 8.61B | 2.47% | 872,518 | - |
| 107 | BAX | Baxter International Inc. | 8.60B | -0.18% | 4,031,825 | 11.24B |
| 108 | HSIC | Henry Schein, Inc. | 8.59B | 1.24% | 715,875 | 13.18B |
| 109 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.56B | 0.15% | 1,005,780 | 1.09B |
| 110 | TEM | Tempus AI, Inc. | 8.46B | -0.19% | 2,467,633 | 1.27B |
| 111 | TECH | Bio-Techne Corporation | 8.42B | 1.26% | 1,276,529 | 1.22B |
| 112 | QGEN | Qiagen N.V. | 8.40B | -0.61% | 967,117 | 2.09B |
| 113 | ICLR | ICON Public Limited Company | 8.37B | -4.00% | 633,331 | 8.10B |
| 114 | CRL | Charles River Laboratories International, Inc. | 8.28B | -3.26% | 1,000,471 | 4.02B |
| 115 | NUVL | Nuvalent, Inc. | 8.15B | -1.63% | 766,304 | - |
| 116 | ATR | AptarGroup, Inc. | 8.04B | - | 267,453 | 3.78B |
| 117 | CYTK | Cytokinetics, Incorporated | 8.00B | -2.68% | 1,001,497 | 88.04M |
| 118 | KRYS | Krystal Biotech, Inc. | 7.65B | 0.33% | 206,797 | 389.13M |
| 119 | BIO | Bio-Rad Laboratories, Inc. | 7.53B | -0.41% | 150,985 | 2.58B |
| 120 | HALO | Halozyme Therapeutics, Inc. | 7.47B | -2.19% | 1,055,639 | 1.40B |
| 121 | MOH | Molina Healthcare, Inc. | 7.47B | 2.86% | 949,268 | 43.56B |
| 122 | IBRX | ImmunityBio, Inc. | 7.31B | -3.01% | 13,202,006 | 113.29M |
| 123 | HQY | HealthEquity, Inc. | 7.05B | -1.45% | 667,317 | 1.31B |
| 124 | KYMR | Kymera Therapeutics, Inc. | 6.96B | -0.15% | 349,362 | 39.21M |
| 125 | GKOS | Glaukos Corporation | 6.77B | 3.42% | 677,385 | 507.44M |
| 126 | BLTE | Belite Bio, Inc | 6.73B | 0.78% | 197,950 | - |
| 127 | ACLX | Arcellx, Inc. | 6.73B | -0.04% | 594,932 | 22.29M |
| 128 | GRFS | Grifols, S.A. | 6.61B | -0.12% | 395,744 | 8.83B |
| 129 | RGEN | Repligen Corporation | 6.60B | -0.70% | 388,852 | 738.26M |
| 130 | PTGX | Protagonist Therapeutics, Inc. | 6.57B | -0.86% | 339,169 | 46.02M |
| 131 | APGE | Apogee Therapeutics, Inc. | 6.20B | -0.39% | 543,983 | - |
| 132 | CNTA | Centessa Pharmaceuticals plc | 6.14B | -0.05% | 2,094,326 | 15.00M |
| 133 | TERN | Terns Pharmaceuticals, Inc. | 6.09B | 0.11% | 6,132,772 | - |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.94B | 0.78% | 442,977 | 189.76M |
| 135 | MIRM | Mirum Pharmaceuticals, Inc. | 5.81B | 2.20% | 303,012 | 521.31M |
| 136 | BLCO | Bausch + Lomb Corporation | 5.80B | -0.81% | 281,822 | 5.10B |
| 137 | COGT | Cogent Biosciences, Inc. | 5.70B | 0.60% | 1,107,093 | - |
| 138 | CGON | CG Oncology, Inc. | 5.70B | 0.10% | 972,655 | 4.04M |
| 139 | PTCT | PTC Therapeutics, Inc. | 5.70B | 1.67% | 461,816 | 1.73B |
| 140 | ALKS | Alkermes plc | 5.67B | -2.18% | 1,708,316 | 1.48B |
| 141 | SRRK | Scholar Rock Holding Corporation | 5.61B | -2.40% | 1,139,610 | - |
| 142 | BRKR | Bruker Corporation | 5.59B | -0.05% | 1,164,003 | 3.44B |
| 143 | CELC | Celcuity Inc. | 5.52B | 1.41% | 650,122 | - |
| 144 | XENE | Xenon Pharmaceuticals Inc. | 5.42B | -0.02% | 1,393,109 | 7.50M |
| 145 | AVTR | Avantor, Inc. | 5.40B | 1.01% | 5,152,249 | 6.55B |
| 146 | CAI | Caris Life Sciences, Inc. | 5.37B | -1.45% | 1,297,650 | 812.03M |
| 147 | ERAS | Erasca, Inc. | 5.32B | -3.87% | 3,956,262 | - |
| 148 | CHE | Chemed Corporation | 5.32B | 1.51% | 126,802 | 2.53B |
| 149 | APLS | Apellis Pharmaceuticals, Inc. | 5.19B | 0.54% | 4,587,212 | 1.00B |
| 150 | PACS | PACS Group, Inc. | 5.12B | 1.28% | 337,489 | 5.29B |
| 151 | TFX | Teleflex Incorporated | 5.08B | -2.35% | 381,653 | 1.99B |
| 152 | IMVT | Immunovant, Inc. | 5.07B | 1.59% | 969,324 | - |
| 153 | TGTX | TG Therapeutics, Inc. | 4.98B | 0.48% | 1,743,366 | 616.29M |
| 154 | LNTH | Lantheus Holdings, Inc. | 4.93B | -0.28% | 378,523 | 1.54B |
| 155 | CRSP | CRISPR Therapeutics AG | 4.72B | -0.73% | 1,038,497 | 3.51M |
| 156 | HIMS | Hims & Hers Health, Inc. | 4.63B | 6.22% | 19,383,568 | 2.35B |
| 157 | FOLD | Amicus Therapeutics, Inc. | 4.54B | 0.07% | 1,007,014 | 634.21M |
| 158 | WAY | Waystar Holding Corp. | 4.53B | -0.46% | 775,583 | 1.10B |
| 159 | DNTH | Dianthus Therapeutics, Inc. | 4.53B | -0.58% | 923,047 | 2.04M |
| 160 | CORT | Corcept Therapeutics Incorporated | 4.35B | -3.86% | 864,694 | 761.41M |
| 161 | OPCH | Option Care Health, Inc. | 4.34B | 0.95% | 750,266 | 5.65B |
| 162 | RDNT | RadNet, Inc. | 4.27B | 0.49% | 458,056 | 2.04B |
| 163 | DOCS | Doximity, Inc. | 4.26B | 1.27% | 1,049,416 | 637.78M |
| 164 | NVST | Envista Holdings Corporation | 4.23B | - | 889,981 | 2.72B |
| 165 | SHC | Sotera Health Company | 4.23B | -0.60% | 2,366,262 | 1.16B |
| 166 | LGND | Ligand Pharmaceuticals Incorporated | 4.06B | 2.01% | 208,745 | 268.09M |
| 167 | MMSI | Merit Medical Systems, Inc. | 4.03B | 0.16% | 470,579 | 1.52B |
| 168 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.95B | 1.26% | 740,837 | 7.70M |
| 169 | AMRX | Amneal Pharmaceuticals, Inc. | 3.94B | -1.04% | 734,630 | 3.02B |
| 170 | VKTX | Viking Therapeutics, Inc. | 3.93B | -2.50% | 2,388,586 | - |
| 171 | BLLN | BillionToOne, Inc. | 3.93B | 7.74% | 327,310 | 305.11M |
| 172 | NAMS | NewAmsterdam Pharma Company N.V. | 3.92B | 3.43% | 1,054,550 | 22.50M |
| 173 | SYRE | Spyre Therapeutics, Inc. | 3.85B | 2.94% | 651,927 | - |
| 174 | ALHC | Alignment Healthcare, Inc. | 3.81B | -0.48% | 1,363,610 | 3.95B |
| 175 | ACAD | ACADIA Pharmaceuticals Inc. | 3.81B | 0.54% | 1,078,871 | 1.07B |
| 176 | OSCR | Oscar Health, Inc. | 3.80B | 7.05% | 5,260,119 | 11.70B |
| 177 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.79B | 1.50% | 675,747 | 677.56M |
| 178 | IRTC | iRhythm Holdings, Inc. | 3.79B | 0.36% | 310,639 | 747.14M |
| 179 | STVN | Stevanato Group S.p.A. | 3.76B | 0.44% | 314,637 | 1.39B |
| 180 | MMED | Minimed Group, Inc. | 3.73B | -5.28% | 861,303 | 2.89B |
| 181 | GPCR | Structure Therapeutics Inc. | 3.67B | -3.20% | 813,345 | - |
| 182 | TMDX | TransMedics Group, Inc. | 3.59B | 4.08% | 617,810 | 605.49M |
| 183 | EWTX | Edgewise Therapeutics, Inc. | 3.52B | -1.50% | 493,351 | - |
| 184 | LIVN | LivaNova PLC | 3.47B | -0.45% | 377,794 | 1.39B |
| 185 | LEGN | Legend Biotech Corporation | 3.45B | -2.40% | 723,360 | 1.03B |
| 186 | LQDA | Liquidia Corporation | 3.32B | -0.08% | 1,007,323 | 158.32M |
| 187 | BKD | Brookdale Senior Living Inc. | 3.30B | -0.43% | 1,499,885 | 3.05B |
| 188 | TWST | Twist Bioscience Corporation | 3.14B | 1.93% | 551,688 | 391.56M |
| 189 | HNGE | Hinge Health, Inc. | 3.09B | 0.54% | 275,523 | 587.86M |
| 190 | ICUI | ICU Medical, Inc. | 3.07B | -0.26% | 145,742 | 2.23B |
| 191 | DNLI | Denali Therapeutics Inc. | 3.07B | -6.15% | 1,570,663 | - |
| 192 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.05B | 1.17% | 569,047 | 588.99M |
| 193 | TLX | Telix Pharmaceuticals Limited | 3.03B | -0.34% | 60,028 | 803.79M |
| 194 | DYN | Dyne Therapeutics, Inc. | 3.03B | -2.60% | 1,015,302 | - |
| 195 | TARS | Tarsus Pharmaceuticals, Inc. | 2.99B | 0.10% | 476,467 | 451.36M |
| 196 | ITGR | Integer Holdings Corporation | 2.95B | -1.40% | 301,017 | 1.85B |
| 197 | TVTX | Travere Therapeutics, Inc. | 2.94B | 4.57% | 2,773,603 | 490.73M |
| 198 | ARQT | Arcutis Biotherapeutics, Inc. | 2.93B | 0.11% | 1,227,236 | 376.07M |
| 199 | SUPN | Supernus Pharmaceuticals, Inc. | 2.91B | 0.12% | 323,799 | 718.95M |
| 200 | TNGX | Tango Therapeutics, Inc. | 2.90B | -6.20% | 1,822,385 | 62.38M |
| 201 | VERA | Vera Therapeutics, Inc. | 2.89B | -1.02% | 1,251,365 | - |
| 202 | IDYA | IDEAYA Biosciences, Inc. | 2.84B | -1.22% | 365,331 | 218.71M |
| 203 | TXG | 10x Genomics, Inc. | 2.80B | -1.97% | 1,477,386 | 642.82M |
| 204 | ORKA | Oruka Therapeutics, Inc. | 2.79B | 5.74% | 1,837,831 | - |
| 205 | ALMS | Alumis Inc. | 2.79B | -6.12% | 1,498,361 | 24.05M |
| 206 | RCUS | Arcus Biosciences, Inc. | 2.79B | -3.14% | 507,092 | 247.00M |
| 207 | HAE | Haemonetics Corporation | 2.72B | 2.87% | 330,231 | 1.32B |
| 208 | PRVA | Privia Health Group, Inc. | 2.71B | 1.79% | 623,831 | 2.12B |
| 209 | SLNO | Soleno Therapeutics, Inc. | 2.70B | 32.31% | 58,021,879 | 190.41M |
| 210 | CON | Concentra Group Holdings Parent, Inc. | 2.70B | 0.48% | 380,393 | 2.16B |
| 211 | PBH | Prestige Consumer Healthcare Inc. | 2.61B | 5.05% | 781,744 | 1.10B |
| 212 | WRBY | Warby Parker Inc. | 2.58B | 3.75% | 1,689,790 | 871.91M |
| 213 | VCYT | Veracyte, Inc. | 2.57B | 0.22% | 278,367 | 517.15M |
| 214 | NHC | National HealthCare Corporation | 2.55B | 0.85% | 111,235 | 1.52B |
| 215 | IRON | Disc Medicine, Inc. | 2.51B | 0.98% | 212,185 | - |
| 216 | LFST | LifeStance Health Group, Inc. | 2.49B | 1.43% | 1,558,658 | 1.42B |
| 217 | HCM | HUTCHMED (China) Limited | 2.49B | 0.19% | 29,366 | 548.51M |
| 218 | LMAT | LeMaitre Vascular, Inc. | 2.49B | 0.62% | 74,530 | 249.60M |
| 219 | AAPG | Ascentage Pharma Group International | 2.44B | 0.33% | 4,243 | 82.08M |
| 220 | GRDN | Guardian Pharmacy Services, Inc. | 2.43B | 1.18% | 716,484 | 1.45B |
| 221 | IMNM | Immunome, Inc. | 2.43B | -1.65% | 566,050 | 6.94M |
| 222 | CLDX | Celldex Therapeutics, Inc. | 2.41B | 1.00% | 1,231,757 | 1.55M |
| 223 | KOD | Kodiak Sciences Inc. | 2.41B | -4.01% | 849,389 | - |
| 224 | BEAM | Beam Therapeutics Inc. | 2.41B | -1.74% | 1,291,907 | 139.74M |
| 225 | SRPT | Sarepta Therapeutics, Inc. | 2.39B | -1.81% | 2,255,066 | 2.20B |
| 226 | MANE | Veradermics, Incorporated | 2.38B | -0.58% | 208,892 | - |
| 227 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.38B | 4.99% | 3,014,663 | 874.84M |
| 228 | ELVN | Enliven Therapeutics, Inc. | 2.33B | 0.28% | 637,995 | - |
| 229 | MLYS | Mineralys Therapeutics, Inc. | 2.33B | 4.67% | 1,392,371 | - |
| 230 | XRAY | DENTSPLY SIRONA Inc. | 2.32B | 0.09% | 1,463,102 | 3.68B |
| 231 | ZLAB | Zai Lab Limited | 2.31B | 0.44% | 464,844 | 460.16M |
| 232 | ACHC | Acadia Healthcare Company, Inc. | 2.29B | 3.96% | 1,937,117 | 3.31B |
| 233 | RARE | Ultragenyx Pharmaceutical Inc. | 2.24B | 1.87% | 1,055,828 | 673.00M |
| 234 | PAHC | Phibro Animal Health Corporation | 2.23B | -1.04% | 179,742 | 1.46B |
| 235 | HTFL | HeartFlow, Inc. | 2.23B | 4.55% | 988,056 | 176.03M |
| 236 | RLAY | Relay Therapeutics, Inc. | 2.23B | -0.72% | 4,721,240 | 15.36M |
| 237 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | 0.05% | 901,601 | 158.18M |
| 238 | ADMA | ADMA Biologics, Inc. | 2.21B | 0.98% | 2,750,585 | 510.17M |
| 239 | ADPT | Adaptive Biotechnologies Corporation | 2.17B | -4.93% | 1,180,293 | 276.98M |
| 240 | NKTR | Nektar Therapeutics | 2.15B | -2.52% | 417,428 | 55.23M |
| 241 | SNDX | Syndax Pharmaceuticals, Inc. | 2.14B | -3.42% | 1,434,982 | 172.35M |
| 242 | AUPH | Aurinia Pharmaceuticals Inc. | 2.13B | 2.50% | 1,336,125 | 283.06M |
| 243 | GRAL | GRAIL, Inc. | 2.12B | -5.91% | 816,737 | 147.17M |
| 244 | TYRA | Tyra Biosciences, Inc. | 2.10B | -1.72% | 1,107,438 | - |
| 245 | NEOG | Neogen Corporation | 2.08B | 1.59% | 1,783,445 | 880.32M |
| 246 | AGIO | Agios Pharmaceuticals, Inc. | 2.04B | -1.14% | 897,651 | 54.03M |
| 247 | DFTX | Definium Therapeutics, Inc. | 2.04B | -1.21% | 1,018,389 | - |
| 248 | SEM | Select Medical Holdings Corporation | 2.03B | 0.18% | 621,002 | 5.45B |
| 249 | BHC | Bausch Health Companies Inc. | 2.00B | 1.12% | 629,521 | 10.27B |
| 250 | WGS | GeneDx Holdings Corp. | 1.95B | 0.62% | 387,348 | 427.54M |
| 251 | GLPG | Galapagos NV | 1.95B | -0.07% | 86,458 | 1.31B |
| 252 | STOK | Stoke Therapeutics, Inc. | 1.94B | 0.15% | 431,223 | 184.42M |
| 253 | AHG | Akso Health Group | 1.93B | 1.35% | 182,010 | 14.84M |
| 254 | ZYME | Zymeworks Inc. | 1.91B | 0.16% | 328,228 | 105.97M |
| 255 | MESO | Mesoblast Limited | 1.90B | 0.41% | 96,873 | 65.38M |
| 256 | PHVS | Pharvaris N.V. | 1.86B | -0.67% | 274,381 | - |
| 257 | CAPR | Capricor Therapeutics, Inc. | 1.82B | -1.34% | 723,649 | 11.13M |
| 258 | ANAB | AnaptysBio, Inc. | 1.79B | 8.24% | 389,122 | 234.60M |
| 259 | ESTA | Establishment Labs Holdings Inc. | 1.77B | 3.46% | 363,557 | 211.08M |
| 260 | MD | Pediatrix Medical Group, Inc. | 1.76B | 2.41% | 519,552 | 1.91B |
| 261 | OCUL | Ocular Therapeutix, Inc. | 1.76B | -4.95% | 2,350,934 | 51.95M |
| 262 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.75B | 5.82% | 2,313,928 | -665.00K |
| 263 | VCEL | Vericel Corporation | 1.74B | -0.18% | 322,558 | 276.26M |
| 264 | PVLA | Palvella Therapeutics, Inc. | 1.72B | -2.92% | 197,744 | - |
| 265 | INVA | Innoviva, Inc. | 1.70B | 0.13% | 322,967 | 411.33M |
| 266 | ADUS | Addus HomeCare Corporation | 1.70B | 2.09% | 192,755 | 1.42B |
| 267 | AXGN | Axogen, Inc. | 1.69B | -5.23% | 1,093,383 | 225.21M |
| 268 | SION | Sionna Therapeutics, Inc. | 1.68B | -7.68% | 163,816 | - |
| 269 | ATEC | Alphatec Holdings, Inc. | 1.66B | 1.29% | 1,080,659 | 764.16M |
| 270 | RXRX | Recursion Pharmaceuticals, Inc. | 1.66B | 1.03% | 7,488,159 | 74.68M |
| 271 | TRVI | Trevi Therapeutics, Inc. | 1.64B | 7.29% | 1,646,618 | - |
| 272 | AHCO | AdaptHealth Corp. | 1.64B | 0.33% | 569,710 | 3.24B |
| 273 | NRIX | Nurix Therapeutics, Inc. | 1.63B | 1.81% | 1,547,162 | 83.98M |
| 274 | AORT | Artivion, Inc. | 1.62B | -2.11% | 491,939 | 441.33M |
| 275 | IMCR | Immunocore Holdings plc | 1.62B | 3.60% | 636,215 | 400.02M |
| 276 | ANIP | ANI Pharmaceuticals, Inc. | 1.61B | 4.03% | 475,255 | 883.37M |
| 277 | HRMY | Harmony Biosciences Holdings, Inc. | 1.60B | -0.11% | 582,674 | 868.45M |
| 278 | SGRY | Surgery Partners, Inc. | 1.58B | 0.99% | 815,061 | 3.31B |
| 279 | OGN | Organon & Co. | 1.57B | -4.87% | 2,378,392 | 6.22B |
| 280 | NTLA | Intellia Therapeutics, Inc. | 1.57B | 1.29% | 1,680,432 | 67.67M |
| 281 | PLSE | Pulse Biosciences, Inc. | 1.56B | -0.26% | 274,059 | 350.00K |
| 282 | INSP | Inspire Medical Systems, Inc. | 1.56B | -1.55% | 898,673 | 911.98M |
| 283 | OCS | Oculis Holding AG | 1.56B | -1.09% | 134,488 | 1.51M |
| 284 | OMCL | Omnicell, Inc. | 1.55B | -0.12% | 132,801 | 1.18B |
| 285 | RAPP | Rapport Therapeutics, Inc. | 1.55B | -3.57% | 191,066 | - |
| 286 | GENB | Generate Biomedicines, Inc. | 1.54B | -12.11% | 279,131 | 31.89M |
| 287 | NBTX | Nanobiotix S.A. | 1.53B | 5.90% | 20,858 | 38.27M |
| 288 | NUVB | Nuvation Bio Inc. | 1.53B | 0.91% | 2,694,652 | 62.90M |
| 289 | SNDA | Sonida Senior Living, Inc. | 1.52B | 0.90% | 457,315 | 336.39M |
| 290 | MBX | MBX Biosciences, Inc. | 1.49B | -5.12% | 361,330 | - |
| 291 | PGEN | Precigen, Inc. | 1.48B | 6.35% | 3,163,457 | 9.68M |
| 292 | UFPT | UFP Technologies, Inc. | 1.48B | -0.01% | 201,315 | 602.80M |
| 293 | DMRA | Damora Therapeutics, Inc. | 1.48B | -2.39% | 158,264 | - |
| 294 | ARDX | Ardelyx, Inc. | 1.46B | 0.51% | 1,248,476 | 407.32M |
| 295 | PRGO | Perrigo Company plc | 1.46B | -2.40% | 2,343,824 | 4.25B |
| 296 | ATRC | AtriCure, Inc. | 1.45B | 0.41% | 297,222 | 534.53M |
| 297 | VIR | Vir Biotechnology, Inc. | 1.45B | - | 964,564 | 68.56M |
| 298 | MAZE | Maze Therapeutics, Inc. | 1.44B | 1.01% | 486,081 | 2.50M |
| 299 | VRDN | Viridian Therapeutics, Inc. | 1.42B | -26.22% | 13,818,700 | 70.85M |
| 300 | SVRA | Savara Inc. | 1.42B | 0.72% | 1,116,355 | - |
| 301 | AVAH | Aveanna Healthcare Holdings Inc. | 1.41B | 1.72% | 848,528 | 2.43B |
| 302 | ATAI | AtaiBeckley Inc. | 1.40B | 1.58% | 3,122,791 | 4.09M |
| 303 | IMTX | Immatics N.V. | 1.38B | -0.39% | 329,608 | 56.67M |
| 304 | BHVN | Biohaven Ltd. | 1.38B | -6.63% | 1,435,280 | - |
| 305 | BCAX | Bicara Therapeutics Inc. | 1.36B | -2.89% | 500,574 | - |
| 306 | IOVA | Iovance Biotherapeutics, Inc. | 1.36B | -4.08% | 9,082,490 | 263.50M |
| 307 | GLUE | Monte Rosa Therapeutics, Inc. | 1.35B | -0.94% | 582,127 | 123.67M |
| 308 | PRCT | PROCEPT BioRobotics Corporation | 1.34B | -5.33% | 1,626,664 | 308.05M |
| 309 | TSHA | Taysha Gene Therapies, Inc. | 1.34B | 6.41% | 3,944,225 | 9.77M |
| 310 | WVE | Wave Life Sciences Ltd. | 1.33B | -2.61% | 2,584,564 | 42.73M |
| 311 | ZBIO | Zenas BioPharma, Inc. | 1.32B | 3.73% | 581,111 | 10.00M |
| 312 | OLMA | Olema Pharmaceuticals, Inc. | 1.32B | 0.73% | 679,547 | - |
| 313 | HCSG | Healthcare Services Group, Inc. | 1.32B | 2.40% | 521,831 | 1.84B |
| 314 | PGNY | Progyny, Inc. | 1.31B | 1.08% | 551,024 | 1.29B |
| 315 | TNDM | Tandem Diabetes Care, Inc. | 1.31B | 3.01% | 1,182,711 | 1.01B |
| 316 | HROW | Harrow, Inc. | 1.31B | -0.51% | 270,196 | 272.30M |
| 317 | ENOV | Enovis Corporation | 1.30B | 0.53% | 497,102 | 2.25B |
| 318 | NVAX | Novavax, Inc. | 1.30B | 3.51% | 2,786,488 | 1.12B |
| 319 | ASTH | Astrana Health, Inc. | 1.29B | 3.79% | 326,958 | 3.18B |
| 320 | ARDT | Ardent Health, Inc. | 1.28B | 3.35% | 248,915 | 6.32B |
| 321 | CRVS | Corvus Pharmaceuticals, Inc. | 1.24B | 0.14% | 535,381 | - |
| 322 | IRMD | IRADIMED CORPORATION | 1.22B | -0.59% | 78,221 | 83.81M |
| 323 | MLTX | MoonLake Immunotherapeutics | 1.22B | -2.19% | 1,017,835 | - |
| 324 | NVCR | NovoCure Limited | 1.20B | - | 655,084 | 655.35M |
| 325 | ALVO | Alvotech | 1.19B | 3.84% | 409,385 | 588.90M |
| 326 | DBVT | DBV Technologies S.A. | 1.17B | -3.32% | 151,038 | 5.64M |
| 327 | PHAR | Pharming Group N.V. | 1.16B | -0.72% | 11,278 | 376.13M |
| 328 | NNNN | Anbio Biotechnology | 1.15B | 1.14% | 15,416 | 6.92M |
| 329 | KMTS | Kestra Medical Technologies, Ltd. | 1.13B | -2.62% | 255,205 | 83.72M |
| 330 | GERN | Geron Corporation | 1.12B | 5.42% | 29,065,685 | 183.88M |
| 331 | USPH | U.S. Physical Therapy, Inc. | 1.12B | 0.41% | 97,198 | 773.34M |
| 332 | SEPN | Septerna, Inc. | 1.11B | -1.59% | 112,307 | 45.95M |
| 333 | AVBP | ArriVent BioPharma, Inc. | 1.10B | 0.32% | 142,351 | - |
| 334 | EYPT | EyePoint, Inc. | 1.09B | -2.16% | 741,685 | 31.37M |
| 335 | QURE | uniQure N.V. | 1.09B | 1.34% | 865,942 | 16.10M |
| 336 | INNV | InnovAge Holding Corp. | 1.08B | 4.73% | 305,251 | 915.37M |
| 337 | QDEL | QuidelOrtho Corporation | 1.08B | -7.94% | 1,653,553 | 2.73B |
| 338 | BFLY | Butterfly Network, Inc. | 1.05B | 0.49% | 2,877,920 | 97.61M |
| 339 | CNMD | CONMED Corporation | 1.05B | -2.04% | 275,719 | 1.37B |
| 340 | PNTG | The Pennant Group, Inc. | 1.05B | 0.88% | 263,142 | 947.71M |
| 341 | XERS | Xeris Biopharma Holdings, Inc. | 1.04B | 0.17% | 892,919 | 291.85M |
| 342 | NEO | NeoGenomics, Inc. | 1.04B | 0.25% | 1,536,504 | 727.33M |
| 343 | IVA | Inventiva S.A. | 1.04B | 3.66% | 1,012,011 | 9.31M |
| 344 | AZTA | Azenta, Inc. | 1.04B | -0.18% | 791,737 | 595.03M |
| 345 | STAA | STAAR Surgical Company | 1.04B | 3.71% | 519,876 | 239.44M |
| 346 | COLL | Collegium Pharmaceutical, Inc. | 1.03B | 0.87% | 273,359 | 780.57M |
| 347 | KALV | KalVista Pharmaceuticals, Inc. | 1.03B | 1.46% | 1,166,257 | 73.62M |
| 348 | ABCL | AbCellera Biologics Inc. | 1.03B | -3.69% | 3,088,850 | 75.13M |
| 349 | MPLT | MapLight Therapeutics, Inc. | 995.38M | 6.80% | 205,734 | - |
| 350 | CMPX | Compass Therapeutics, Inc. | 988.68M | 0.73% | 2,696,258 | 850.00K |
| 351 | CLOV | Clover Health Investments, Corp. | 981.13M | 8.72% | 6,884,992 | 1.92B |
| 352 | SSII | SS Innovations International, Inc. | 961.71M | -3.80% | 26,662 | 42.48M |
| 353 | CRON | Cronos Group Inc. | 958.86M | 2.33% | 993,262 | 146.59M |
| 354 | CTMX | CytomX Therapeutics, Inc. | 951.18M | -3.51% | 3,415,876 | 76.20M |
| 355 | TDOC | Teladoc Health, Inc. | 949.07M | 0.95% | 1,782,678 | 2.53B |
| 356 | GHRS | GH Research PLC | 939.13M | 3.91% | 138,661 | - |
| 357 | AMPH | Amphastar Pharmaceuticals, Inc. | 933.72M | 0.64% | 241,663 | 719.89M |
| 358 | INBX | Inhibrx Biosciences, Inc. | 930.76M | 0.30% | 134,221 | 1.30M |
| 359 | ANNX | Annexon, Inc. | 930.75M | 5.45% | 2,586,540 | - |
| 360 | BLFS | BioLife Solutions, Inc. | 930.74M | -1.23% | 115,982 | 96.21M |
| 361 | EVO | Evotec SE | 921.82M | 1.16% | 35,993 | 887.40M |
| 362 | CDNA | CareDx, Inc. | 912.68M | -2.68% | 235,868 | 379.81M |
| 363 | XNCR | Xencor, Inc. | 912.33M | -2.89% | 732,829 | 125.58M |
| 364 | JANX | Janux Therapeutics, Inc. | 908.82M | 0.67% | 1,010,268 | 10.00M |
| 365 | URGN | UroGen Pharma Ltd. | 905.98M | -1.12% | 389,437 | 109.79M |
| 366 | AKTS | Aktis Oncology, Inc. | 904.87M | -5.76% | 279,575 | 6.50M |
| 367 | CGEM | Cullinan Therapeutics, Inc. | 903.05M | 3.40% | 974,443 | - |
| 368 | PCRX | Pacira BioSciences, Inc. | 901.71M | -1.89% | 314,483 | 726.41M |
| 369 | OPK | OPKO Health, Inc. | 895.70M | 3.51% | 2,398,584 | 606.88M |
| 370 | ORIC | ORIC Pharmaceuticals, Inc. | 894.19M | 0.22% | 2,057,407 | - |
| 371 | PHAT | Phathom Pharmaceuticals, Inc. | 886.49M | -0.79% | 479,513 | 175.11M |
| 372 | VOR | Vor Biopharma Inc. | 885.66M | -9.45% | 1,393,854 | - |
| 373 | EVMN | Evommune, Inc. | 885.33M | 3.63% | 151,800 | 13.00M |
| 374 | ABUS | Arbutus Biopharma Corporation | 871.83M | -0.45% | 569,043 | 14.08M |
| 375 | CERT | Certara, Inc. | 868.90M | 0.92% | 3,376,705 | 418.84M |
| 376 | TALK | Talkspace, Inc. | 868.80M | 0.39% | 2,867,299 | 228.87M |
| 377 | INMD | InMode Ltd. | 868.65M | -0.58% | 274,420 | 370.50M |
| 378 | SANA | Sana Biotechnology, Inc. | 859.31M | 0.63% | 1,528,334 | - |
| 379 | LMRI | Lumexa Imaging Holdings, Inc. | 859.22M | -4.39% | 763,963 | 1.02B |
| 380 | SDGR | Schrödinger, Inc. | 850.47M | -0.52% | 566,804 | 255.87M |
| 381 | FTRE | Fortrea Holdings Inc. | 842.44M | -4.66% | 1,030,819 | 2.72B |
| 382 | SPRY | ARS Pharmaceuticals, Inc. | 833.10M | 1.08% | 1,002,311 | 84.28M |
| 383 | TBPH | Theravance Biopharma, Inc. | 829.04M | 0.50% | 442,482 | 107.46M |
| 384 | SLS | SELLAS Life Sciences Group, Inc. | 813.51M | 9.69% | 5,045,019 | - |
| 385 | JBIO | Jade Biosciences, Inc. | 797.44M | 4.39% | 664,155 | - |
| 386 | MNKD | MannKind Corporation | 788.74M | 2.40% | 2,545,771 | 348.97M |
| 387 | OMER | Omeros Corporation | 783.68M | -0.14% | 917,449 | - |
| 388 | BIOA | BioAge Labs, Inc. | 777.98M | 0.17% | 253,444 | 9.00M |
| 389 | MGTX | MeiraGTx Holdings plc | 775.37M | 3.70% | 1,052,037 | 81.39M |
| 390 | TLRY | Tilray Brands, Inc. | 775.35M | 1.60% | 3,538,947 | 858.28M |
| 391 | DSGN | Design Therapeutics, Inc. | 772.75M | 11.58% | 698,083 | - |
| 392 | SLDB | Solid Biosciences Inc. | 761.55M | 3.34% | 855,807 | - |
| 393 | MRVI | Maravai LifeSciences Holdings, Inc. | 758.35M | - | 1,567,312 | 185.74M |
| 394 | SGP | SpyGlass Pharma, Inc. | 757.45M | 0.89% | 120,066 | - |
| 395 | BVS | Bioventus Inc. | 750.06M | 0.56% | 369,345 | 568.09M |
| 396 | KURA | Kura Oncology, Inc. | 749.92M | -1.39% | 649,688 | 67.48M |
| 397 | TENX | Tenax Therapeutics, Inc. | 748.47M | -0.90% | 826,843 | - |
| 398 | CMPS | COMPASS Pathways plc | 741.31M | -0.69% | 1,082,587 | - |
| 399 | OMDA | Omada Health, Inc. | 741.28M | - | 433,701 | 260.21M |
| 400 | CSTL | Castle Biosciences, Inc. | 735.25M | -0.44% | 154,063 | 344.23M |
| 401 | IART | Integra LifeSciences Holdings Corporation | 725.60M | -2.31% | 483,074 | 1.64B |
| 402 | RLMD | Relmada Therapeutics, Inc. | 723.74M | -1.29% | 636,263 | - |
| 403 | ANRO | Alto Neuroscience, Inc. | 719.73M | 3.92% | 330,240 | - |
| 404 | ARVN | Arvinas, Inc. | 717.64M | 3.41% | 961,489 | 262.60M |
| 405 | AMN | AMN Healthcare Services, Inc. | 717.46M | 1.98% | 410,524 | 2.73B |
| 406 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 713.09M | - | 468,729 | - |
| 407 | GDRX | GoodRx Holdings, Inc. | 712.55M | 1.46% | 815,214 | 796.85M |
| 408 | EHAB | Enhabit, Inc. | 708.60M | -0.21% | 724,622 | 1.06B |
| 409 | REPL | Replimune Group, Inc. | 705.17M | 1.55% | 3,012,338 | - |
| 410 | NUTX | Nutex Health Inc. | 701.36M | -0.27% | 177,680 | 875.26M |
| 411 | DRUG | Bright Minds Biosciences Inc. | 689.00M | 4.93% | 152,820 | - |
| 412 | PSNL | Personalis, Inc. | 688.78M | - | 604,823 | 69.65M |
| 413 | CBLL | CeriBell, Inc. | 683.94M | -2.15% | 177,371 | 89.06M |
| 414 | ETON | Eton Pharmaceuticals, Inc. | 682.11M | 0.04% | 275,088 | 79.95M |
| 415 | LBRX | LB Pharmaceuticals Inc | 681.56M | 4.87% | 399,407 | - |
| 416 | LXRX | Lexicon Pharmaceuticals, Inc. | 673.65M | - | 1,586,752 | 49.80M |
| 417 | ESPR | Esperion Therapeutics, Inc. | 654.87M | -2.30% | 9,477,459 | 403.14M |
| 418 | GYRE | Gyre Therapeutics, Inc. | 650.16M | - | 68,063 | 116.59M |
| 419 | CBIO | Crescent Biopharma, Inc. | 643.69M | -0.10% | 243,945 | 10.84M |
| 420 | AVNS | Avanos Medical, Inc. | 643.20M | -0.86% | 371,913 | 701.20M |
| 421 | ALLO | Allogene Therapeutics, Inc. | 633.82M | 4.84% | 3,023,968 | 22.00K |
| 422 | DRTS | Alpha Tau Medical Ltd. | 601.11M | -1.30% | 217,333 | - |
| 423 | HSTM | HealthStream, Inc. | 598.87M | -0.24% | 142,600 | 304.06M |
| 424 | OCGN | Ocugen, Inc. | 598.08M | -1.12% | 4,116,372 | 4.41M |
| 425 | PRME | Prime Medicine, Inc. | 591.45M | 0.60% | 1,851,938 | 4.63M |
| 426 | SIBN | SI-BONE, Inc. | 583.42M | 0.69% | 606,787 | 200.93M |
| 427 | CTKB | Cytek Biosciences, Inc. | 581.05M | -0.22% | 349,333 | 201.49M |
| 428 | MDXG | MiMedx Group, Inc. | 576.44M | -1.02% | 806,127 | 418.63M |
| 429 | IRWD | Ironwood Pharmaceuticals, Inc. | 575.60M | -0.28% | 937,037 | 296.15M |
| 430 | ZURA | Zura Bio Limited | 574.98M | 0.50% | 1,227,927 | - |
| 431 | ZVRA | Zevra Therapeutics, Inc. | 571.85M | 3.62% | 828,649 | 106.47M |
| 432 | AGMB | AgomAb Therapeutics NV | 570.22M | 9.14% | 92,083 | - |
| 433 | TECX | Tectonic Therapeutic, Inc. | 562.92M | -1.77% | 150,779 | - |
| 434 | CRMD | CorMedix Inc. | 559.68M | 0.43% | 626,140 | 311.71M |
| 435 | TCMD | Tactile Systems Technology, Inc. | 558.98M | -0.12% | 110,805 | 329.52M |
| 436 | PHR | Phreesia, Inc. | 555.98M | 9.32% | 3,308,365 | 480.59M |
| 437 | BWAY | BrainsWay Ltd. | 546.75M | -7.30% | 271,953 | 52.23M |
| 438 | PROK | ProKidney Corp. | 546.47M | -4.74% | 646,639 | 893.00K |
| 439 | VALN | Valneva SE | 543.61M | -2.30% | 25,910 | 205.07M |
| 440 | KYTX | Kyverna Therapeutics, Inc. | 542.28M | 1.13% | 518,237 | - |
| 441 | PRTA | Prothena Corporation plc | 540.48M | 1.83% | 347,847 | 9.68M |
| 442 | UPB | Upstream Bio, Inc. | 528.96M | 2.32% | 412,891 | 2.85M |
| 443 | EMBC | Embecta Corp. | 528.83M | 0.90% | 661,165 | 1.08B |
| 444 | ACRS | Aclaris Therapeutics, Inc. | 528.18M | -9.52% | 2,008,942 | 7.83M |
| 445 | LRMR | Larimar Therapeutics, Inc. | 524.61M | 5.43% | 1,867,671 | - |
| 446 | FULC | Fulcrum Therapeutics, Inc. | 521.48M | -2.61% | 689,291 | 80.00M |
| 447 | EIKN | Eikon Therapeutics, Inc. | 511.07M | -4.65% | 338,614 | - |
| 448 | FDMT | 4D Molecular Therapeutics, Inc. | 507.45M | 4.85% | 460,175 | 85.21M |
| 449 | AVR | Anteris Technologies Global Corp. | 507.04M | -6.18% | 460,099 | 1.91M |
| 450 | RIGL | Rigel Pharmaceuticals, Inc. | 505.42M | -0.62% | 162,285 | 294.28M |
| 451 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 452 | LYEL | Lyell Immunopharma, Inc. | 502.74M | 1.70% | 56,285 | 36.00K |
| 453 | CTNM | Contineum Therapeutics, Inc. | 501.80M | - | 118,285 | - |
| 454 | YDES | YD Bio Limited | 500.89M | -4.13% | 11,400 | 510.36K |
| 455 | TRDA | Entrada Therapeutics, Inc. | 499.68M | 5.55% | 177,864 | 25.42M |
| 456 | AQST | Aquestive Therapeutics, Inc. | 499.16M | -0.97% | 772,380 | 44.55M |
| 457 | CATX | Perspective Therapeutics, Inc. | 499.03M | -0.68% | 493,514 | 884.00K |
| 458 | FBRX | Forte Biosciences, Inc. | 496.23M | 3.36% | 142,992 | - |
| 459 | NPCE | NeuroPace, Inc. | 491.54M | -0.34% | 141,997 | 99.99M |
| 460 | VTVT | vTv Therapeutics Inc. | 490.67M | -3.96% | 48,403 | 17.00K |
| 461 | STTK | Shattuck Labs, Inc. | 485.21M | 5.61% | 399,371 | 1.00M |
| 462 | ENGN | enGene Holdings Inc. | 485.00M | 8.22% | 209,118 | - |
| 463 | VSTM | Verastem, Inc. | 481.34M | -2.66% | 1,197,151 | 30.91M |
| 464 | KMDA | Kamada Ltd. | 479.08M | -2.24% | 54,844 | 180.46M |
| 465 | FLGT | Fulgent Genetics, Inc. | 473.63M | -2.38% | 269,786 | 322.67M |
| 466 | OFIX | Orthofix Medical Inc. | 472.50M | 2.08% | 186,927 | 822.31M |
| 467 | AVIR | Atea Pharmaceuticals, Inc. | 467.68M | 1.91% | 413,270 | - |
| 468 | ADCT | ADC Therapeutics SA | 466.25M | -2.91% | 627,009 | 81.36M |
| 469 | ASMB | Assembly Biosciences, Inc. | 465.25M | 1.10% | 106,343 | 72.30M |
| 470 | IMMX | Immix Biopharma, Inc. | 454.97M | -3.91% | 500,449 | - |
| 471 | RGNX | REGENXBIO Inc. | 454.19M | 3.17% | 463,707 | 170.44M |
| 472 | ABSI | Absci Corporation | 453.71M | -3.10% | 4,446,100 | 2.80M |
| 473 | VREX | Varex Imaging Corporation | 442.67M | 0.57% | 105,961 | 854.40M |
| 474 | BBNX | Beta Bionics, Inc. | 441.60M | 0.20% | 419,492 | 100.25M |
| 475 | EPRX | Eupraxia Pharmaceuticals Inc. | 439.78M | -0.98% | 121,490 | - |
| 476 | MYGN | Myriad Genetics, Inc. | 436.68M | -1.68% | 473,795 | 824.50M |
| 477 | ALT | Altimmune, Inc. | 433.25M | -0.30% | 2,121,253 | 41.00K |
| 478 | AUNA | Auna S.A. | 432.24M | 3.18% | 178,388 | 1.30B |
| 479 | PACB | Pacific Biosciences of California, Inc. | 428.84M | 5.97% | 6,397,372 | 160.01M |
| 480 | AURA | Aura Biosciences, Inc. | 428.53M | 2.14% | 499,126 | - |
| 481 | LXEO | Lexeo Therapeutics, Inc. | 427.48M | 0.87% | 5,149,953 | - |
| 482 | NAUT | Nautilus Biotechnology, Inc. | 421.46M | 0.76% | 192,833 | - |
| 483 | EBS | Emergent BioSolutions Inc. | 418.32M | -1.58% | 448,663 | 742.90M |
| 484 | VNDA | Vanda Pharmaceuticals Inc. | 411.98M | -0.43% | 653,211 | 216.11M |
| 485 | ANGO | AngioDynamics, Inc. | 410.15M | -4.56% | 1,051,122 | 313.73M |
| 486 | KIDS | OrthoPediatrics Corp. | 402.94M | -0.75% | 72,481 | 236.35M |
| 487 | XOMA | XOMA Royalty Corporation | 402.16M | 2.33% | 95,821 | 52.15M |
| 488 | DNA | Ginkgo Bioworks Holdings, Inc. | 399.88M | -0.43% | 769,268 | 170.16M |
| 489 | WEAV | Weave Communications, Inc. | 399.53M | 3.46% | 1,096,987 | 239.02M |
| 490 | CYH | Community Health Systems, Inc. | 397.58M | 0.34% | 589,909 | 12.49B |
| 491 | STRO | Sutro Biopharma, Inc. | 396.79M | 0.71% | 147,617 | 102.48M |
| 492 | NRC | National Research Corporation | 394.20M | 0.99% | 84,909 | 137.39M |
| 493 | IPSC | Century Therapeutics, Inc. | 393.59M | 2.82% | 1,473,133 | 109.16M |
| 494 | ARMP | Armata Pharmaceuticals, Inc. | 386.48M | 3.63% | 116,092 | 4.90M |
| 495 | ENTA | Enanta Pharmaceuticals, Inc. | 384.51M | 0.84% | 96,451 | 66.98M |
| 496 | NMRA | Neumora Therapeutics, Inc. | 384.11M | 5.50% | 1,704,909 | - |
| 497 | LCTX | Lineage Cell Therapeutics, Inc. | 383.59M | -1.91% | 1,227,073 | 14.56M |
| 498 | CGC | Canopy Growth Corporation | 383.14M | 2.00% | 7,073,446 | 203.04M |
| 499 | VMD | Viemed Healthcare, Inc. | 376.76M | 1.35% | 257,374 | 270.28M |
| 500 | BNTC | Benitec Biopharma Inc. | 376.46M | 0.64% | 59,168 | - |